Navigation Links
Synaptics Reports Record Results for First Quarter of Fiscal 2009
Date:10/23/2008

rends in target markets; and its assessment of consumer demands for various applications. Synaptics cautions that these statements are qualified by important factors that could cause actual results to differ materially from those reflected by the forward-looking statements contained herein. Such factors include, but are not limited to, (a) demand for Synaptics' products, (b) market demand for OEMs' products using Synaptics' solutions, (c) changing market demand trends in the markets it serves, and (d) other risks as identified from time to time in Synaptics' SEC reports, including Quarterly Reports on Form 10-Q and the Annual Report on Form 10-K for the fiscal year ended June 30, 2008. All forward-looking statements are based on information available to Synaptics on the date hereof, and Synaptics assumes no obligation to update such statements.

(Tables to Follow)

SYNAPTICS INCORPORATED

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

September 30, June 30,

2008 2008

Assets

Current assets:

Cash and cash equivalents $112,063 $96,218

Short term investments 40,427 50,298

Total cash, cash equivalents,

and short-term investments 152,490 146,516

Receivables, net of allowances of

$539 and $539, respectively 86,598 69,362

Inventories 25,138 21,065

Prepaid expenses and other current

assets 3,853 3,417

Total current assets 268,079 240,360

Property and equipmen
'/>"/>

SOURCE Synaptics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Synaptics to Report First Quarter Results on October 23
2. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
3. GEN reports on novel tools for deciphering biological networks
4. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
5. LSUHSC research reports new method to protect brain cells from diseases like Alzheimers
6. Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results
7. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
8. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
9. Limiting fructose may boost weight loss, UT Southwestern researcher reports
10. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
11. BIO-key(R) Reports First Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... PHILADELPHIA Cigarette smoking and alcohol consu...gly predicts the patient,s future risk of death, a...ew study show a similar effect among those who con...ost cancer survivors are counseled to quit smoking... percent continued to smoke even after their cance...
(Date:12/2/2009)..., PHILADELPHIA Exposure to secondhand smoke for ...y increase the risk of breast cancer, even in wome...e question of whether exposure to side-stream smok... is unresolved," said Peggy Reynolds, Ph.D., senio...ncer Center,s Berkeley office. "While no single ep...
(Date:12/2/2009)... Recalls of ground beef, peanut butter, and other ...nd concern about food safety. They also are quietl...uipment and fostering new food safety regulations....he current issue of Chemical & Engineering News ,...te Editor Jyllian Kemsley and Senior Correspondent...
Breaking Biology News(10 mins):Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Mediterranean Diet May Help Prevent Depression 58895 1Mediterranean Diet May Help Prevent Depression 58895 2Mediterranean Diet May Help Prevent Depression 58895 3SAGE launches Genes 26amp 3B Cancer 58891 1SAGE launches Genes 26amp 3B Cancer 58891 2Fewer U S Schools Selling Less Nutritious Food and Beverages 58888 1Fewer U S Schools Selling Less Nutritious Food and Beverages 58888 2
...motherapy drugs to specific cancer cells without t...ay be possible thanks to a nanoscale drug delivery...Department of Energy,s Ames Laboratory. , Using ti... carry drugs inside living cells, Ames Laboratory ...o control whether or not the particle delivers its...
...om the University of Alberta, the Yerkes National ...e Emory Transplant Center has successfully transpl...ls into monkeys, a procedure the researchers say r... critical supply problem in clinical islet cell tr..., along with recent work at the University of Minn...
...ound probes built by researchers at Duke,s Pratt S...s of dogs. The engineers said their demonstration ...r view during human endoscopic surgeries in which ...cisions. , If the probes prove beneficial in human...nd safer endoscopic surgeries, said the Duke engin...
Other Biology News:Cellular scale drug delivery from the inside out 2Cellular scale drug delivery from the inside out 3Diabetes researchers pioneer islet cell xenotransplantation in primate studies 23D ultrasound device poised to advance minimally invasive surgery 23D ultrasound device poised to advance minimally invasive surgery 3
(Date:12/3/2009)...RNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. ...on the development of compounds for the treatment ...ounced that it has completed the last patient visi...1. ,, The FDG-PET trial enrolled 52 patients a...ada including Massachusetts General Hospital, Moun...
(Date:12/3/2009)...PRNewswire-FirstCall/ -- Inverness Medical Innovat...ling individuals to take charge of their health at...health management, has declared a dividend of $3.0...Preferred Stock ( IMA-PB). The dividend will be pa...are equal to the quotient of (a) $3.00 divided by ...
(Date:12/2/2009)...PRNewswire-FirstCall/ -- Martek Biosciences Corpor...ends to release the results of its fourth quarter ...oximately 4:00 p.m. Eastern Time (ET). Following ... conference call to discuss these results with inv...call live via webcast by visiting Martek,s web sit...
(Date:12/2/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Carbondioxide Incubators - A Global ....com/p0164368/Carbondioxide-Incubators---A-Global-... most critical equipment used in microbiology, gen...r providing a controlled environment to grow and s...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...orts the potential for QLT,s drug elution technolo...r pressure, VANCOUVER, May 12 /PRNewswire-FirstCa...today results from a proof of concept trial conduc...ivery, Inc., of its punctal plug,drug delivery tec...elution,technology was effective in controlling in...
... May 12 WaferGen Biosystems,Inc. (OTC Bulletin Bo...t,gene expression, genotyping, cell biology and st...Alnoor Shivji, President and Chief Executive,Offic...odman & Renshaw,Fifth Annual Global Healthcare Con...08, at the Le Meridien Beach Plaza Hotel in Monte ...
...f., May 9 Bionovo, Inc.,(Nasdaq: BNVI ) today an...uarter Results, The company did not report any re...evenues for the three months ended March 31, 2007 ...logy transfer agreement with United,Biotechnology ...inated the,agreement following notice of material ...
Other Biology Technology:QLT reports initial proof of concept data for punctal plug delivery technology 2QLT reports initial proof of concept data for punctal plug delivery technology 3QLT reports initial proof of concept data for punctal plug delivery technology 4WaferGen to Present at the Rodman and Renshaw Fifth Annual Global Healthcare Conference 2Bionovo Reports First Quarter 2008 Financial Results 2Bionovo Reports First Quarter 2008 Financial Results 3Bionovo Reports First Quarter 2008 Financial Results 4Bionovo Reports First Quarter 2008 Financial Results 5Bionovo Reports First Quarter 2008 Financial Results 6
Chicken Anti-Nucleobindin 1 (NUCB1) Antibody, Unconjugated from CHEMICON
Anti-Presenilin-1, N-terminus Polyclonal Antibody, Unconjugated from CHEMICON
Goat Anti-Syne-1 (N-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Human Kallikrein 1 Monoclonal Antibody, Unconjugated, Clone 323803 from R&D Systems
Biology Products: